China Medical System Valuation

CHSYFDelisted Stock  USD 0.93  0.00  0.00%   
Today, the firm appears to be overvalued. China Medical System shows a prevailing Real Value of $0.79 per share. The current price of the firm is $0.93. Our model approximates the value of China Medical System from analyzing the firm fundamentals such as Current Valuation of 3.84 B, profit margin of 0.36 %, and Return On Equity of 0.24 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
0.93
Please note that China Medical's price fluctuation is very steady at this time. Calculation of the real value of China Medical System is based on 3 months time horizon. Increasing China Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the China pink sheet is determined by what a typical buyer is willing to pay for full or partial control of China Medical System. Since China Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of China Pink Sheet. However, China Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.93 Real  0.79 Hype  0.93 Naive  0.93
The real value of China Pink Sheet, also known as its intrinsic value, is the underlying worth of China Medical System Company, which is reflected in its stock price. It is based on China Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of China Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
0.79
Real Value
1.02
Upside
Estimating the potential upside or downside of China Medical System helps investors to forecast how China pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of China Medical more accurately as focusing exclusively on China Medical's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.930.930.93
Details
Hype
Prediction
LowEstimatedHigh
0.930.930.93
Details
Naive
Forecast
LowNext ValueHigh
0.930.930.93
Details

China Medical Total Value Analysis

China Medical System is currently anticipated to have takeover price of 3.84 B with market capitalization of 4.19 B, debt of 573.81 M, and cash on hands of 5.25 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the China Medical fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
3.84 B
4.19 B
573.81 M
5.25 B

China Medical Investor Information

About 50.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.71. Some equities with similar Price to Book (P/B) outperform the market in the long run. China Medical System last dividend was issued on the 6th of September 2022. Based on the analysis of China Medical's profitability, liquidity, and operating efficiency, China Medical System is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.

China Medical Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. China Medical has an asset utilization ratio of 52.74 percent. This implies that the Company is making $0.53 for each dollar of assets. An increasing asset utilization means that China Medical System is more efficient with each dollar of assets it utilizes for everyday operations.

China Medical Ownership Allocation

China Medical holds a total of 2.45 Billion outstanding shares. China Medical System retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

China Medical Profitability Analysis

The company reported the revenue of 8.34 B. Net Income was 3.02 B with profit before overhead, payroll, taxes, and interest of 6.25 B.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates China Medical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in China Medical and how it compares across the competition.

About China Medical Valuation

The pink sheet valuation mechanism determines China Medical's current worth on a weekly basis. Our valuation model uses a comparative analysis of China Medical. We calculate exposure to China Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of China Medical's related companies.
China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the Peoples Republic of China. China Medical System Holdings Limited is a subsidiary of Treasure Sea Limited. China Medical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 5454 people.

8 Steps to conduct China Medical's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates China Medical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct China Medical's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain China Medical's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine China Medical's revenue streams: Identify China Medical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research China Medical's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish China Medical's growth potential: Evaluate China Medical's management, business model, and growth potential.
  • Determine China Medical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate China Medical's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

China Medical Growth Indicators

Investing in growth stocks can be very risky. If the company such as China Medical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding2.5 B
Quarterly Earnings Growth Y O Y0.112
Forward Price Earnings7.2254
Retained Earnings10.6 B
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Consideration for investing in China Pink Sheet

If you are still planning to invest in China Medical System check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the China Medical's history and understand the potential risks before investing.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
CEOs Directory
Screen CEOs from public companies around the world
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Fundamental Analysis
View fundamental data based on most recent published financial statements